Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLOBAZAM for Obsessive-compulsive disorder: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where CLOBAZAM was used for Obsessive-compulsive disorder.

Most Reported Side Effects for CLOBAZAM

Side Effect Reports % Deaths Hosp.
Drug ineffective 1,918 18.1% 93 614
Seizure 1,787 16.9% 37 525
Off label use 957 9.0% 82 366
Somnolence 890 8.4% 24 291
Foetal exposure during pregnancy 531 5.0% 39 83
Multiple-drug resistance 486 4.6% 50 79
Epilepsy 464 4.4% 23 158
Drug interaction 431 4.1% 6 170
Fatigue 418 3.9% 0 64
Status epilepticus 366 3.5% 56 170
Drug resistance 324 3.1% 6 50
Fall 311 2.9% 4 193
Condition aggravated 310 2.9% 6 135
Generalised tonic-clonic seizure 269 2.5% 14 82
Product use issue 250 2.4% 32 138

Other Indications for CLOBAZAM

Epilepsy (2,840) Product used for unknown indication (2,535) Seizure (1,569) Lennox-gastaut syndrome (586) Partial seizures (565) Status epilepticus (437) Generalised tonic-clonic seizure (307) Severe myoclonic epilepsy of infancy (267) Epileptic encephalopathy (149) Focal dyscognitive seizures (143)

Other Drugs Used for Obsessive-compulsive disorder

SERTRALINE (1,114) RISPERIDONE (642) FLUOXETINE (637) ARIPIPRAZOLE (586) FLUVOXAMINE (321) CLOMIPRAMINE (305) QUETIAPINE (266) PAROXETINE (204) VENLAFAXINE (203) ESCITALOPRAM OXALATE (198)

Related Pages

CLOBAZAM Full Profile All Obsessive-compulsive disorder Drugs CLOBAZAM Demographics CLOBAZAM Timeline